VC-backed Chinese B2B fabrics trading platform Baibu is making the transition from online marketplace to cloud-based consolidator of the country's fragmented factories
China is the dominant force in soft fabrics, generating RMB1.5 trillion ($217 billion) in revenue in 2018, which amounts to 23% of the global total. But the manufacturers responsible for this output are...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.